Crizotinib Inhibits Metabolic Inactivation of Gemcitabine in c-Met-driven Pancreatic Carcinoma

A. Avan; V. Caretti; N. Funel; E. Galvani; M. Maftouh; R.J. Honeywell; T. Lagerweij; O. van Tellingen; D. Campani; D. Fuchs; H.M. Verheul; G.J. Schuurhuis; U. Boggi; G.J. Peters; T. Wurdinger; E. Giovannetti

doi:https://doi.org/10.1158/0008-5472.CAN-13-0837

Crizotinib Inhibits Metabolic Inactivation of Gemcitabine in c-Met-driven Pancreatic Carcinoma

A. Avan, V. Caretti, N. Funel, E. Galvani, M. Maftouh, R.J. Honeywell, T. Lagerweij, O. van Tellingen, D. Campani, D. Fuchs, H.M. Verheul, G.J. Schuurhuis, U. Boggi, G.J. Peters, T. Wurdinger, E. Giovannetti

Research output: Contribution to journal › Article › Academic › peer-review

81 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	6745-6756
Journal	Cancer research
Volume	73
Issue number	22
DOIs	https://doi.org/10.1158/0008-5472.CAN-13-0837
Publication status	Published - 2013

Access to Document

https://doi.org/10.1158/0008-5472.CAN-13-0837

Cite this

Avan, A., Caretti, V., Funel, N., Galvani, E., Maftouh, M., Honeywell, R. J., Lagerweij, T., van Tellingen, O., Campani, D., Fuchs, D., Verheul, H. M., Schuurhuis, G. J., Boggi, U., Peters, G. J., Wurdinger, T., & Giovannetti, E. (2013). Crizotinib Inhibits Metabolic Inactivation of Gemcitabine in c-Met-driven Pancreatic Carcinoma. Cancer research, 73(22), 6745-6756. https://doi.org/10.1158/0008-5472.CAN-13-0837

@article{f8d81479d1ae48adaabe173ebc260885,

title = "Crizotinib Inhibits Metabolic Inactivation of Gemcitabine in c-Met-driven Pancreatic Carcinoma",

author = "A. Avan and V. Caretti and N. Funel and E. Galvani and M. Maftouh and R.J. Honeywell and T. Lagerweij and {van Tellingen}, O. and D. Campani and D. Fuchs and H.M. Verheul and G.J. Schuurhuis and U. Boggi and G.J. Peters and T. Wurdinger and E. Giovannetti",

year = "2013",

doi = "https://doi.org/10.1158/0008-5472.CAN-13-0837",

language = "Undefined/Unknown",

volume = "73",

pages = "6745--6756",

journal = "Cancer research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "22",

}

Avan, A, Caretti, V, Funel, N, Galvani, E, Maftouh, M, Honeywell, RJ, Lagerweij, T, van Tellingen, O, Campani, D, Fuchs, D, Verheul, HM, Schuurhuis, GJ, Boggi, U, Peters, GJ , Wurdinger, T & Giovannetti, E 2013, 'Crizotinib Inhibits Metabolic Inactivation of Gemcitabine in c-Met-driven Pancreatic Carcinoma', Cancer research, vol. 73, no. 22, pp. 6745-6756. https://doi.org/10.1158/0008-5472.CAN-13-0837

TY - JOUR

T1 - Crizotinib Inhibits Metabolic Inactivation of Gemcitabine in c-Met-driven Pancreatic Carcinoma

AU - Avan, A.

AU - Caretti, V.

AU - Funel, N.

AU - Galvani, E.

AU - Maftouh, M.

AU - Honeywell, R.J.

AU - Lagerweij, T.

AU - van Tellingen, O.

AU - Campani, D.

AU - Fuchs, D.

AU - Verheul, H.M.

AU - Schuurhuis, G.J.

AU - Boggi, U.

AU - Peters, G.J.

AU - Wurdinger, T.

AU - Giovannetti, E.

PY - 2013

Y1 - 2013

U2 - https://doi.org/10.1158/0008-5472.CAN-13-0837

DO - https://doi.org/10.1158/0008-5472.CAN-13-0837

M3 - Article

C2 - 24085787

SN - 0008-5472

VL - 73

SP - 6745

EP - 6756

JO - Cancer research

JF - Cancer research

IS - 22

ER -